NFKB1 and periodontitis: A recent study involving healthy controls and patients with chronic periodontitis showed that the activation of NF-κB (p50/p65) is significantly upregulated in periodontal disease tissues, suggesting that NF-κB inhibitors may be promising agents for managing periodontitis [95].